Tumgik
#Keys of Henoch
miraridoctor · 2 months
Text
I frequently care for children with serious blood disorders like hemolytic uremic syndrome (HUS) and idiopathic thrombocytopenic purpura (ITP). I also often receive referrals to evaluate kids with symptoms concerning for Henoch-Schönlein purpura (HSP... #Mirari #MirariDoctor #MirariColdPlasma #ColdPlasma
0 notes
Link
0 notes
doomanddead · 2 years
Text
Contemplate the Infinite with Keys of Henoch
Tumblr media
One of the great things about being a small reviewer is that it’s actually possible for me to check out all the bands that follow me on Instagram. Every month I pay back the love by reviewing one. This month’s pick is Keys of Henoch. 
The Düsseldorf duo describes their sound as “Black Drone Doom.” Their “Rehersal Jam December 2019” really emphasizes the “drone” and “doom” parts of that recipe. 
The track unfolds gradually, like an enormous cosmic flower opening its petals and yawning wide.  The guitar stretches and whines over a developing drone. Desert vibes abound. Every note is sparse, controlled, and intentional. The mysterious soundscape unsticks you from time, transporting you to the liminal space between worlds. This nine-and-a-half-minute synth and guitar jam is an otherworldly odyssey sure to leave you breathless. 
Wherever Keys of Henoch takes us next, I’m looking forward to the journey. 
Rehearsal Jam December 2019 by Keys of Henoch
0 notes
ichayalovesyou · 3 years
Text
WhumpTrek~Return To Tomorrow (Henoch dies, and Spock “dies” with him)
It’s so unsettling to see “Spock” emote, but low key even though Henoch was evil that death is soooo sad. Nimoy is such a good actor, you could see the pure fear in his eyes as he begged Sargon for his life, just, wow. That “let me... trans... fer” before he collapses especially 😳
But 😭 the way Kirk runs over to Spock even though he knows he’s gone is just 💔 “Spock...” like he can barely get it out and he has his hand on him and owwwww 😢
Then the way he LIGHTS UP like a Christmas tree when Sargon’s like “I could not allow the sacrifice of someone so close to you.” And it’s just AWWWWW! 🥺
I love that Jim only gives a crap about Chapel for about 2 seconds and is just like 🤩😍 that Spock’s alive 😂
This one’ll take you through aaaaaall the emotions lmao.
48 notes · View notes
asheewrites · 6 years
Text
RaphMazinates 6
I talked to them both about a threesome. They both were blushing. When I mentioned the third partner, they blushed in a way that said they didn't mind in the slightest. Henoch agreed to let her decide on what would happen in bed. She had quite some ideas, I shrugged and happily agreed. We all decided Mister Loew's apartment was the best choice for the meeting - no other roommates, he had keys, no one would actually ask any questions... ... I didn't have a very long way home...
Everything was set up, I met Gabrielle, we rung at "Mister Loew"'s door, I kissed him and pushed him back into his flat, I closed the door while he kissed her - he still was a bit of an ass-guy, eve with women, it seemed. There were a few words exchanged, Gabrielle got used to Henoch's dick in record time and she did become rather flustered at being filled both ways. Henoch still liked to be commanded around, especially in round two. And that was that, I supposed. They both were exhausted enough, she had slept in with her head on his adorably  hairy chest... he with an arm wrapped around both our waists. All right! I climbed out of bed, he put his other arm around her as well. He shall enjoy that before she wakes halfway up and struggles free. Anyway. The condoms were all removed and appropriately in the garbage bins, I applied a blanket to the both of them... and then tiptoed out of there. Mission success! Or at least a night of good sex had happened. And Henoch was a morning-after guy. So that would certainly work out. Meanwhile, I let myself out and ascended to the top floor. I was glad to come home and see the silver haired beanpole at the table, scribbling notes. "I see you had an exciting evening," I said, toeing my shoes off. I was faced with a towel. Literally. Because he had thrown it over my head. Kind of impressive, from half the room away. When I had pulled it down, he said: "Take a shower this time, then you can lurk around" So open to conversation... I rolled my eyes and - for peace of home - did just that. Admittedly, it felt nice to be... clean. Sweat drying on your skin actually is just as unappealing as it sounds like. ... but the satisfied tiredness goes, too. And any semblance of good mood, since one is supposed to sleep after sex. At least after exhausting sex. So he would have to cheer me up now. At least with company. As insufferable as he was. I walked out with a towel around my hips and opened my mouth. "Your pyjamas are in the lefthand-side shelf," he said, oly looking up for a second. I closed my mouth again, scowled and then opened it again to say: "Can't you at least let me make a quip?!" With a huff, I still turned around and got... "Raph, this is a ball of fluff" "True," he said. And that was that. The ball of fluff turned out to be a hoodie. Which didn't scratch. And pants. Which were reasonably un-fluffy on the inside. Then I stepped out: "Why did you feel the need to dress me as a labradoodle?" Since I certainly felt like one. "What... is that supposed to be?" He frowned at me. But then shook is head and made a beckoning motion: "Come here" He patted the sofa space next to him. What was happening? But alright. I walked over, careful not to topple his tower of notes: "Alright, beanpole, what's up?" He grabbed a pillow and put it on his lap, patted that as well. ... after ten seconds of staring, I said, doubtful: "Should I... sit down on your lap?" It was unlikely, since he still had his book. "What? No!" He grabbed my shoulder and pulled me sideways, putting my head on his lap. I let it happen, since I was still confused. And... well... I couldn't say he ever did something to harm me. Now he put a blanket on me. I pulled my legs up. Then I cleared my throat: "You.. .are aware this is... odd, yes?" "Oh. Yes. But you are odd. And whenever you come home after you had sex, you start moping and annoy me. And the next morning, there is always oatmeal" "... you realise nothing of this explains what just happened. Anyway, did you just admit to *not liking* something? Food-wise?" But at least the PJs were comfy. He handed me my phone and earbuds and said, with an eyeroll in his voice: "Oatmeal is perfectly fine, but it's... a weird consistency. Slimey. Anyway. You need some more oxytocin" I wriggled one earbud in and put on a few calm tunes: "... so you put me in your lap" He actually had a food-preference. Maybe he was not a robot after all. "Yes. And put you in soft, warm fabric," he resettled himself a little, taking a smaller book in his hand. And the other... went into my hair. "... are you petting me?" I had almost startled away from the touch. And sounded incredulous, even to my ears. There was a bit of a defensive tone when he said: "You let a lot of people touch you. And this should work" ... I noticed I didn't mind. Ah well: "Work how?" "Well, you should be less annoying and have a better mood tomorrow morning," he continued the pets, but took a different place every few seconds. I yawned. Then said: "You're using me as a test subject" "Then I botched it. If you are aware it's a test it's likely not working," he flipped a page in his small book, one handed. "... you're still totally keeping notes" "Maybe," he shrugged. "I'll totally still annoy you," I'd tell him all about this night. In all the ways it totally had worked. "I'm counting on it," he ruffled my hair. If I woke up with a crick in my neck, I could still murder him.
1 note · View note
Vasculitis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
Ranging from mild to life threatening, short term to life long, Vasculitis is a term for a group of rare diseases that have in common, a condition that destroys blood vessels by inflammation. Affecting both sexes and all ages, vasculitis is caused by leukocyte migration and can affect arteries and veins in the body. Lymphangitis can also be considered as a type of vasculitis.
View Report:  https://www.transparencymarketresearch.com/vasculitis-market.html
Fever, weight loss, abdominal pain, myocardial infraction, arthralgia and others are the possible symptoms of vasculitis. This disorder can affect the blood vessels such as arteries, capillaries and veins in the body as it results in poor blood flow to tissues throughout the body, such as the lungs, nerves and skin.  If the blood vessel is inflamed it blocks or closes the path for blood flow that leads to aneurysm. Shortness of breath, numbness in hand or foot, red spots on the skin, lumps or sores are some of the common symptoms of Vasculitis. Though vasculitis of the kidneys may produce no symptoms at first, but it still remains a serious predicament. Often requiring treatment with immunosuppressive drugs, Vasculitics diseases are inflammatory health problems whose early detection and treatment can prevent permanent damage. Glucocorticoids comprises an integral part of the medication used to treat vasculitis. The dosage and the length of the treatment depends on the severity of the disease and the personal history of the patient. An autoimmune disease where the body comes under attack by its own immune system, some cases of Vasculitis are also caused by reactions to medicines.
Vasculitis is a very rare disease and some of the types of vasculitis diseases are mentioned below:
By large vessel vasculitis
Behçet’s Disease
Cogan’s Syndrome
Giant Cell Arteritis
Polymyalgia Rheumatica
Takayasu’s Arteritis
By medium vessel vasculitis
Buerger’s Disease
Central Nervous System Vasculitis
Kawasaki Disease
Polyarteritis Nodosa
Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14966
By small vessel vasculitis
Churg-Strauss Syndrome
Essential Mixed Cryoglobulinemia
Henoch-Schönlein Purpura
Hypersensitivity Vasculitis
Microscopic Polyangiitis
Wegener’s Granulomatosis
Rising incidences of metabolic disorders and circulatory diseases would accentuate the growth of this disease. Center of Disease Control and Prevention (CDC) estimated that in the year 2013 around 8,000,000 people were diagnosed with peripheral arterial disease (PAD) and is expected to grow significantly in near future owing to sedentary and changing lifestyle. This, the above mentioned factors drive the growth of this market globally. However, lack of awareness is one of the restraining factor of this market.
Geographically, North America is the leading region for the global vasculitis market owing to increasing healthcare awareness. In addition, rise in circulatory diseases namely, peripheral vascular diseases also accentuates the growth in this region. The market in Asia-Pacific region is expected to grow at a significant due to rise in disposable income and increasing healthcare awareness.
Request TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=14966
Vasculitis Market Key Players
Some of the key players engaged in developing vasculitis therapeutics market are Novartis AG, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., RNL BIO Co., Ltd., Teijin Pharma Limited, Anthera Pharmaceuticals‚ Inc., Human Genome Sciences, Inc.¸ Troikaa Pharmaceuticals Ltd., and Genentech, Inc. among others.
0 notes
Text
Vasculitis Market Projected to Garner Significant Revenues by 2024
Ranging from mild to life threatening, short term to life long, Vasculitis is a term for a group of rare diseases that have in common, a condition that destroys blood vessels by inflammation. Affecting both sexes and all ages, vasculitis is caused by leukocyte migration and can affect arteries and veins in the body. Lymphangitis can also be considered as a type of vasculitis. Fever, weight loss, abdominal pain, myocardial infraction, arthralgia and others are the possible symptoms of vasculitis. This disorder can affect the blood vessels such as arteries, capillaries and veins in the body as it results in poor blood flow to tissues throughout the body, such as the lungs, nerves and skin.  If the blood vessel is inflamed it blocks or closes the path for blood flow that leads to aneurysm.
Read Report Overview: https://www.transparencymarketresearch.com/vasculitis-market.html
Shortness of breath, numbness in hand or foot, red spots on the skin, lumps or sores are some of the common symptoms of Vasculitis. Though vasculitis of the kidneys may produce no symptoms at first, but it still remains a serious predicament. Often requiring treatment with immunosuppressive drugs, Vasculitics diseases are inflammatory health problems whose early detection and treatment can prevent permanent damage. Glucocorticoids comprises an integral part of the medication used to treat vasculitis. The dosage and the length of the treatment depends on the severity of the disease and the personal history of the patient. An autoimmune disease where the body comes under attack by its own immune system, some cases of Vasculitis are also caused by reactions to medicines.
Vasculitis is a very rare disease and some of the types of vasculitis diseases are mentioned below:
By large vessel vasculitis
Behçet’s Disease
Cogan’s Syndrome
Giant Cell Arteritis
Polymyalgia Rheumatica
Takayasu’s Arteritis
By medium vessel vasculitis
Buerger’s Disease
Central Nervous System Vasculitis
Kawasaki Disease
Polyarteritis Nodosa
By small vessel vasculitis
Churg-Strauss Syndrome
Essential Mixed Cryoglobulinemia
Henoch-Schönlein Purpura
Hypersensitivity Vasculitis
Microscopic Polyangiitis
Wegener’s Granulomatosis
Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14966
Rising incidences of metabolic disorders and circulatory diseases would accentuate the growth of this disease. Center of Disease Control and Prevention (CDC) estimated that in the year 2013 around 8,000,000 people were diagnosed with peripheral arterial disease (PAD) and is expected to grow significantly in near future owing to sedentary and changing lifestyle. This, the above mentioned factors drive the growth of this market globally. However, lack of awareness is one of the restraining factor of this market.
Geographically, North America is the leading region for the global vasculitis market owing to increasing healthcare awareness. In addition, rise in circulatory diseases namely, peripheral vascular diseases also accentuates the growth in this region. The market in Asia-Pacific region is expected to grow at a significant due to rise in disposable income and increasing healthcare awareness.
Request For TOC : https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=14966
Vasculitis Market Key Players
Some of the key players engaged in developing vasculitis therapeutics market are Novartis AG, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., RNL BIO Co., Ltd., Teijin Pharma Limited, Anthera Pharmaceuticals‚ Inc., Human Genome Sciences, Inc.¸ Troikaa Pharmaceuticals Ltd., and Genentech, Inc. among others.
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Website: http://www.transparencymarketresearch.com/
0 notes
Text
Vasculitis Market - Competitive Analysis and Forecast 2024
Ranging from mild to life threatening, short term to life long, Vasculitis is a term for a group of rare diseases that have in common, a condition that destroys blood vessels by inflammation. Affecting both sexes and all ages, vasculitis is caused by leukocyte migration and can affect arteries and veins in the body. Lymphangitis can also be considered as a type of vasculitis. Fever, weight loss, abdominal pain, myocardial infraction, arthralgia and others are the possible symptoms of vasculitis. This disorder can affect the blood vessels such as arteries, capillaries and veins in the body as it results in poor blood flow to tissues throughout the body, such as the lungs, nerves and skin.  If the blood vessel is inflamed it blocks or closes the path for blood flow that leads to aneurysm. Shortness of breath, numbness in hand or foot, red spots on the skin, lumps or sores are some of the common symptoms of Vasculitis.
Though vasculitis of the kidneys may produce no symptoms at first, but it still remains a serious predicament. Often requiring treatment with immunosuppressive drugs, Vasculitics diseases are inflammatory health problems whose early detection and treatment can prevent permanent damage. Glucocorticoids comprises an integral part of the medication used to treat vasculitis. The dosage and the length of the treatment depends on the severity of the disease and the personal history of the patient. An autoimmune disease where the body comes under attack by its own immune system, some cases of Vasculitis are also caused by reactions to medicines.
Request Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14966
Vasculitis is a very rare disease and some of the types of vasculitis diseases are mentioned below:
By large vessel vasculitis
Behçet's Disease
Cogan's Syndrome
Giant Cell Arteritis
Polymyalgia Rheumatica
Takayasu's Arteritis
By medium vessel vasculitis
Buerger's Disease
Central Nervous System Vasculitis
Kawasaki Disease
Polyarteritis Nodosa
By small vessel vasculitis
Churg-Strauss Syndrome
Essential Mixed Cryoglobulinemia
Henoch-Schönlein Purpura
Hypersensitivity Vasculitis
Microscopic Polyangiitis
Wegener's Granulomatosis
Rising incidences of metabolic disorders and circulatory diseases would accentuate the growth of this disease. Center of Disease Control and Prevention (CDC) estimated that in the year 2013 around 8,000,000 people were diagnosed with peripheral arterial disease (PAD) and is expected to grow significantly in near future owing to sedentary and changing lifestyle. This, the above mentioned factors drive the growth of this market globally. However, lack of awareness is one of the restraining factor of this market.
Report Details @ https://www.transparencymarketresearch.com/vasculitis-market.html
Geographically, North America is the leading region for the global vasculitis market owing to increasing healthcare awareness. In addition, rise in circulatory diseases namely, peripheral vascular diseases also accentuates the growth in this region. The market in Asia-Pacific region is expected to grow at a significant due to rise in disposable income and increasing healthcare awareness.
Vasculitis Market Key Players
Some of the key players engaged in developing vasculitis therapeutics market are Novartis AG, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., RNL BIO Co., Ltd., Teijin Pharma Limited, Anthera Pharmaceuticals‚ Inc., Human Genome Sciences, Inc.¸ Troikaa Pharmaceuticals Ltd., and Genentech, Inc. among others.
Request Pre Book @ https://www.transparencymarketresearch.com/checkout.php?rep_id=14966&ltype=S
0 notes
smitadeshmukh123 · 7 years
Text
New Trends of Vasculitis Market with Worldwide Industry Analysis to 2024
Ranging from mild to life threatening, short term to life long, Vasculitis is a term for a group of rare diseases that have in common, a condition that destroys blood vessels by inflammation. Affecting both sexes and all ages, vasculitis is caused by leukocyte migration and can affect arteries and veins in the body. Lymphangitis can also be considered as a type of vasculitis. Fever, weight loss, abdominal pain, myocardial infraction, arthralgia and others are the possible symptoms of vasculitis. This disorder can affect the blood vessels such as arteries, capillaries and veins in the body as it results in poor blood flow to tissues throughout the body, such as the lungs, nerves and skin. If the blood vessel is inflamed it blocks or closes the path for blood flow that leads to aneurysm. Shortness of breath, numbness in hand or foot, red spots on the skin, lumps or sores are some of the common symptoms of Vasculitis. Though vasculitis of the kidneys may produce no symptoms at first, but it still remains a serious predicament. Often requiring treatment with immunosuppressive drugs, Vasculitics diseases are inflammatory health problems whose early detection and treatment can prevent permanent damage. Glucocorticoids comprises an integral part of the medication used to treat vasculitis. The dosage and the length of the treatment depends on the severity of the disease and the personal history of the patient. An autoimmune disease where the body comes under attack by its own immune system, some cases of Vasculitis are also caused by reactions to medicines.
Read Full Report: http://www.transparencymarketresearch.com/vasculitis-market.html
Vasculitis is a very rare disease and some of the types of vasculitis diseases are mentioned below:
By large vessel vasculitis
Behçet's Disease
Cogan's Syndrome
Giant Cell Arteritis
Polymyalgia Rheumatica
Takayasu's Arteritis
By medium vessel vasculitis
Buerger's Disease
Central Nervous System Vasculitis
Kawasaki Disease
Polyarteritis Nodosa
By small vessel vasculitis
Churg-Strauss Syndrome
Essential Mixed Cryoglobulinemia
Henoch-Schönlein Purpura
Hypersensitivity Vasculitis
Microscopic Polyangiitis
Wegener's Granulomatosis
Rising incidences of metabolic disorders and circulatory diseases would accentuate the growth of this disease. Center of Disease Control and Prevention (CDC) estimated that in the year 2013 around 8,000,000 people were diagnosed with peripheral arterial disease (PAD) and is expected to grow significantly in near future owing to sedentary and changing lifestyle. This, the above mentioned factors drive the growth of this market globally. However, lack of awareness is one of the restraining factor of this market.
Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14966
Geographically, North America is the leading region for the global vasculitis market owing to increasing healthcare awareness. In addition, rise in circulatory diseases namely, peripheral vascular diseases also accentuates the growth in this region. The market in Asia-Pacific region is expected to grow at a significant due to rise in disposable income and increasing healthcare awareness.
Vasculitis Market Key Players
Some of the key players engaged in developing vasculitis therapeutics market are Novartis AG, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., RNL BIO Co., Ltd., Teijin Pharma Limited, Anthera Pharmaceuticals‚ Inc., Human Genome Sciences, Inc.¸ Troikaa Pharmaceuticals Ltd., and Genentech, Inc. among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
0 notes
miraridoctor · 2 months
Text
Henoch-Schönlein purpura (HSP) manifests in diverse ways, from subtle symptoms to end organ-threatening disease. Optimizing outcomes requires accurate diagnosis guiding management. This article explores key facets of the diagnostic workup. Introduct... #Mirari #MirariDoctor #MirariColdPlasma #ColdPlasma
0 notes
miraridoctor · 2 months
Text
Henoch-Schönlein purpura (henoch schonlein purpura), often abbreviated as HSP, is an IgA-mediated, autoimmune, hypersensitivity vasculitis that can affect multiple organs. As an authoritative health writer and patient advocate, I want to provide usef... #Mirari #MirariDoctor #MirariColdPlasma #ColdPlasma
0 notes
miraridoctor · 3 months
Text
Henoch-Schönlein purpura (HSP) is an intricate pediatric condition involving inflammation and leakage from small blood vessels throughout the body. This complex immune-mediated disorder displays an array of symptoms stemming from IgA vascular deposit... #Mirari #MirariDoctor #MirariColdPlasma #ColdPlasma
0 notes
asheewrites · 6 years
Text
Communication is Key.
I yawned. It’s been a long day. But it’s also been the last day. Provisional teaching was over for a while. Actual university was ahead.
But for now? A full week of peace. I would enjoy it.
Teaching was a blessing, but it was also rather draining, if you needed to work up a reputation first.
I was glad to be home. A pot of spicy lentil soup was good company. And there would be a series I could watch on the internet. I’d made a list. I would find something and just be lazy for the rest of the day.
I’d earned it.
This was the situation I was in: My day was finished, the soup getting warmer on the lowest setting, I had gotten rid of my pants and now I could simply deflate, a little music playing in the background until my food was warm enough to consume.
I let out a sigh, sinking into my couch. Home.
At this very moment, my phone… chimed. Like a muted bell. And vibrated. Once.
And that caused me to wrinkle my forehead and make a bit of a face. It even even made me freeze up.
Of course, a phone chiming, in and of itself, was not all too unusual. Phones are supposed to ring. And they are, on occasion, supposed to vibrate as well.
But. There was a problem.
Actually, there were several problems.
First: This was not my ringtone. It was a somehow not-grating tone. And… that meant it definitely wasn’t on the phone, because I’d have used it otherwise.
Second: I never set my phone to vibrate. It was an odd feeling. Chest or pants pocket, it was strange.
But the strangest one was the third: My the battery had run out on my way home. I hadn’t been able to look up when the ETA of my train. And that it rang and vibrated now actually made me feel betrayed.
I fished the offending piece of electronics out of my pants.
And I would have pressed the power button and unlocked, but… there was a message on the phone.
Greetings, mortal
I blinked. Once. Twice.
There was nothing else on the there. Just the letters. Simple and white. Arial, I supposed.
No app-signature, no frame, nothing.
I tried to pull down the menu.
The menu did not appear. But the text changed.
Your phone will resume operating as per usual as soon as the message to you has been delivered.
Still the same type of letters. I stared at it. This phone had been empty.
But there were letters now. And they changed. So, obviously, it was not empty.
With a frown, I fished for the loading cable at the side of the couch and connected it with my phone.
The tiny battery symbol appeared at the upper right corner. Showing a battery and the tiny loading-bolt. Also the ‘0 %’. With the battery filling.
Well, that was not how it usually was. But… I didn’t actually pay muc attention to the behaviour of my phone when it was empty, so… maybe?
The text had changed again:
I am the Metatron, as you are aware, I am the voice of God.
Again, I stared at the screen. This was all a bit weird. I hadn’t heard of this virus before. Or a virus like this. I tried to pull down the menu again.
Not much luck.
We have contacted you to plan and execute the first divine miracle in over 400 years. You are supposed to be the human representative in the council.
… what.
This was a rather elaborate prank, but maybe I should simply switch it off. Which I tried, by pressing the power button. For three seconds. Five. Ten. Mh.
When I let go of the button to press a little harder, the text changed.
We wish to impede your life as little as possible, but seek input from mortals. Therefore, we propose the usage of a messaging app.
I did not exactly see how this was a messaging app. As there were simply messages displayed on my phone, which now had 4 % battery-power. And apparently wasn’t switched on.
When I took out the battery and removed the cable and the display still was not switching off, I got a little nervous.
We are aware your name is Henoch Loew.
Make that a little more nervous.
We are also aware you do believe in higher powers and are a genuinely good person.
Well. At least they got… a good opinion of me?!
We are aware the genuine nature of this proposal is doubtful.
No shit, Sherlock. This proposal was also terribly impossible and freaking me out a little.
If you wish to outright deny participation at this juncture, you have now the opportunity to do so. We will never contact you again.
There was now a keyboard on screen. I stared at it. Stared at it for a good, long while. This was very, very strange.
After maybe two minutes, the text changed again:
If you wish to participate and become part of the council, you will converse with angels and demons with a very low exposure to the human realm and no previous contact with one of your kind. You will plan and execute a suitable divine miracle and expand your own knowledge and the knowledge of the celestial beings you will converse with.
There was still a keyboard. So now I typed. Carefully, because this was still insane:
Can I ask some questions before?
Because I deserved that, and not telling me shit before I’m supposed to agree to some insane stuff was… insane. Also: I would see if this wasn’t just… I don’t know. Programmed or something. This was WEIRD.
Of course you can. Please, go ahead.
I frowned. This was so very strange.
What does Black Pudding taste like?
I thought this was… far enough away from the original topic and needed some actual human interference.
It is also called blood sausage. I never tasted it, but the high nutritional value ad strong natural flavours would have a favourable taste to most, ignoring any pre-evaluations of eating clogged blood.
I stared at the answer. It’s certainly not an answer that comes up first on google. And it’s… somewhat sensible? I didn’t know?
Are there other questions?
A lot. Jepp. So, I typed.
Why me?!
Because that was a good question.
You are an open minded human being that tries to better themselves constantly, you are a minority in your given community, you do not struggle for survival, but have to and are able to work for a living. You own a phone. With the lifestyle you chose, we would not impose in an overdue fashion. There was also a randomised factor
Another moment to stare at the screen.
That is not very fair. Or impartial. Or just.
Or anything. This was… did I mention this was weird?!
I did not claim it was. You are the human chosen by chance and circumstance. We seek to broaden the horizons of all involved individuals. You are the first, but we hope not the last human being we contact.
I simply did not know what to think or say? This was… not an ultimatum or a threat or anything. This was just… I didn’t even know what it was!
What do I have to do, then?!
That’s a thing to say.
Converse with your conversation partners, decide on a miracle to execute on earth. Renew the connection between our plane and yours in a sensible manner.
There was a lot of staring going on.
What if I fuck up?!
This whole thing was still insane.
There is no such thing. We wish to learn. No harm can come from communication between individuals that work towards a common goal.
I made a face at the phone.
The project will be monitored as well. Nothing harmful will come off of it. And you may stop at any given time without negative consequence.
I stared at the phone without a battery and energy source and…
I could go the the TV or make photos and expose this to everyone and it will be a great show and everyone will see!
There was no answer for a few seconds.
It would be a miracle without much impact, but yes, it would be possible. We believe it is not something you desire.
They were right about that.
So that’s a no strings attached… group project.
It sounded like it.
Yes, it could be characterised as such. I would like to ask for politeness towards your group partners, but I believe that is common etiquette in your world and practised by you as a person.
Well, this person was not wrong.
And I noticed that I was actually considering this.
I mean… this was very, very weird. But… I could stop any time? There were no strings attached? Well. Even if it was an elaborate prank, I would not give them my credit card number, so…
I suppose I will receive instructions how to talk to the other members of the group?
Yes, you would, if you accepted your position
What the hell.
Then yes, I accept my position in the council until further notice.
The screen changed again.
Welcome to Devinype
1 note · View note
Vasculitis Market : Competitive Strategies, Regional Analysis Forecast 2024
Ranging from mild to life threatening, short term to life long, Vasculitis is a term for a group of rare diseases that have in common, a condition that destroys blood vessels by inflammation. Affecting both sexes and all ages, vasculitis is caused by leukocyte migration and can affect arteries and veins in the body. Lymphangitis can also be considered as a type of vasculitis.
View Report: https://www.transparencymarketresearch.com/dry-heat-therapy-market.html
Fever, weight loss, abdominal pain, myocardial infraction, arthralgia and others are the possible symptoms of vasculitis. This disorder can affect the blood vessels such as arteries, capillaries and veins in the body as it results in poor blood flow to tissues throughout the body, such as the lungs, nerves and skin.  If the blood vessel is inflamed it blocks or closes the path for blood flow that leads to aneurysm. Shortness of breath, numbness in hand or foot, red spots on the skin, lumps or sores are some of the common symptoms of Vasculitis. Though vasculitis of the kidneys may produce no symptoms at first, but it still remains a serious predicament. Often requiring treatment with immunosuppressive drugs, Vasculitics diseases are inflammatory health problems whose early detection and treatment can prevent permanent damage. Glucocorticoids comprises an integral part of the medication used to treat vasculitis. The dosage and the length of the treatment depends on the severity of the disease and the personal history of the patient. An autoimmune disease where the body comes under attack by its own immune system, some cases of Vasculitis are also caused by reactions to medicines.
Vasculitis is a very rare disease and some of the types of vasculitis diseases are mentioned below:
By large vessel vasculitis
Behçet’s Disease
Cogan’s Syndrome
Giant Cell Arteritis
Polymyalgia Rheumatica
Takayasu’s Arteritis
By medium vessel vasculitis
Buerger’s Disease
Central Nervous System Vasculitis
Kawasaki Disease
Polyarteritis Nodosa
Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14966
By small vessel vasculitis
Churg-Strauss Syndrome
Essential Mixed Cryoglobulinemia
Henoch-Schönlein Purpura
Hypersensitivity Vasculitis
Microscopic Polyangiitis
Wegener’s Granulomatosis
Rising incidences of metabolic disorders and circulatory diseases would accentuate the growth of this disease. Center of Disease Control and Prevention (CDC) estimated that in the year 2013 around 8,000,000 people were diagnosed with peripheral arterial disease (PAD) and is expected to grow significantly in near future owing to sedentary and changing lifestyle. This, the above mentioned factors drive the growth of this market globally. However, lack of awareness is one of the restraining factor of this market.
Geographically, North America is the leading region for the global vasculitis market owing to increasing healthcare awareness. In addition, rise in circulatory diseases namely, peripheral vascular diseases also accentuates the growth in this region. The market in Asia-Pacific region is expected to grow at a significant due to rise in disposable income and increasing healthcare awareness.
Request TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=14966
Vasculitis Market Key Players
Some of the key players engaged in developing vasculitis therapeutics market are Novartis AG, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., RNL BIO Co., Ltd., Teijin Pharma Limited, Anthera Pharmaceuticals‚ Inc., Human Genome Sciences, Inc.¸ Troikaa Pharmaceuticals Ltd., and Genentech, Inc. among others.
0 notes